Analystreport

Phathom Pharmaceuticals (NASDAQ: PHAT) is now covered by analysts at Goldman Sachs Group Inc. They set a "neutral" rating on the stock.

Phathom Pharmaceuticals, Inc.  (PHAT) 
Last phathom pharmaceuticals, inc. earnings: 3/19 08:31 am Check Earnings Report